Extracorporeal lung perfusion (ex-vivo lung perfusion)

Current Opinion in Organ Transplantation

Volumn 21, Issue 3, 2016, Pages 329-335

  Cypel, Marcelo ^a   Keshavjee, Shaf ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

ex vivo lung perfusion; ex vivo organ repair; improving lung transplant outcomes; increasing availability of donor lungs; normothermic preservation

Indexed keywords

BIOLOGICAL MARKER;

BIOREACTOR; BRAIN DEATH; EX VIVO STUDY; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL LUNG PERFUSION; HEART DEATH; HUMAN; LUNG PERFUSION; LUNG REGENERATION; LUNG TRANSPLANTATION; ORGAN DONOR; ORGAN PRESERVATION; PRECLINICAL STUDY; PRIMARY GRAFT DYSFUNCTION; REVIEW; TISSUE REGENERATION; LUNG; PATHOLOGY; PERFUSION; PROCEDURES; VASCULARIZATION;

EXTRACORPOREAL CIRCULATION; HUMANS; LUNG; LUNG TRANSPLANTATION; PERFUSION;

EID: 84966460134     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000320     Document Type: Review

References (52)

1. Punch JD, Hayes DH, LaPorte FB, et al. Organ donation and utilization in the United States, 1996-2005. Am J Transplant 2007; 7:1327-1338.
2. De Meester J, Smits J, Persijn G, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20:518-524.
3. Lederer DJ, Arcasoy SM, Wilt JS, et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174:659-664.
4. Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practi. J Heart Lung Transplant 1998; 17:525-531.
5. Fischer S, Matte-Martyn A, De Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001; 121:594-596.
6. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995; 46:235-247.
7. Muller C, Hoffmann H, Bittmann I, et al. Hypothermic storage alone in lung preservation for transplantation: a metabolic, light microscopic, and functional analysis after 18 h of preservation. Transplantation 1997; 63:625-630.
8. Pegg DE. Organ preservation. Surg Clin N Am 1986; 66:617-632.
9. Carrel A, Lindbergh CA. The culture of whole organs. Science 1935; 81:621-623.
10. Jirsch DW, Fisk RL, Couves CM. Ex vivo evaluation of stored lungs. Ann Thorac Surg 1970; 10:163-168.
11. Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from non-heartbeating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76:244-252.
12. Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007; 83:2191-2194.
13. Ingemansson R, Eyjolfsson A, Mared L, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009; 87:255-260.
14. Erasmus ME, Fernhout MH, Elstrodt JM, Rakhorst G. Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int 2006; 19:589-593.
15. Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27:1319-1325.
16. D'Armini AM, Roberts CS, Griffith PK, et al. When does the lung die? I. Histochemical evidence of pulmonary viability after "death". J Heart Lung Transplant 1994; 13:741-747.
17. Alessandrini F, D'Armini AM, Roberts CS, et al. When does the lung die? II. Ultrastructural evidence of pulmonary viability after "death". J Heart Lung Transplant 1994; 13:748-757.
18. Petak F, Habre W, Hantos Z, et al. Effects of pulmonary vascular pressures and flow on airway and parenchymal mechanics in isolated rat lungs. J Appl Physiol 2002; 92:169-178.
19. Broccard AF, Vannay C, Feihl F, Schaller MD. Impact of low pulmonary vascular pressure on ventilator-induced lung injury. Crit Care Med 2002; 30:2183-2190.
20. Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9:2262-2269.
21. Cypel M, Liu M, Rubacha M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009; 1:4ra9.
22. Yeung JC, Koike T, Cypel M, et al. Airway pressure and compliance in the evaluation of donor lung injury during protective ex vivo lung perfusion in a porcine brain death model. J Heart Lung Transplant 2011; 30 (Suppl):S143.
23. Yeung JC, Cypel M, Machuca T, et al. Ex vivo evaluation of brain dead donor lungs: PO2 is not enough. J Heart Lung Transplant 2012; 31 (Suppl):S218-S219.
24. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364:1431-1440.
25. Cypel M, Yeung J, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thor Cardiovasc Surg 2012; 144:1200-1206.
26. Wallinder A, Ricksten SE, Hansson C, et al. Ex-vivo perfusion and transplantation of initially rejected donor lungs. J Heart Lung Transplant 2012; 31 (Suppl):S98.
27. Warnecke G, Haverich A, Massard G, et al. The INSPIRE International Lung Trial with the Organ Care System Technology (OCSTM). J Heart Lung Transplant 2012; 31 (Suppl):S115.
28. Souilamas R, Souilamas JI Jr, Saueressig M, Briot R. Advanced normothermic ex vivo lung maintenance using the mobile Organ Care System. J Heart Lung Transplant 2011; 30:847-848.
29. Cypel M, Levvey B, Van Raemdonck D, et al. International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report. J Heart Lung Transplant 2015; 34:1278-1282.
30. Reeb J, Keshavjee S, Cypel M. Successful lung transplantation from a donation after cardiocirculatory death donor taking more than 120 min to cardiac arrest after withdrawal of life support therapies. J Heart Lung Transplant 2016; 35:258-259.
31. Machuca TN, Mercier O, Collaud S, et al. Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion. Am J Transplant 2015; 15:993-1002.
32. Gomez-de-Antonio D, Campo-Canaveral JL, Crowley S, et al. Clinical lung transplantation from uncontrolled non-heart-beating donors revisited. J Heart Lung Transplant 2012; 31:349-353.
33. de Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 2007; 26:529-534.
34. Rega FR, Vanaudenaerde BM, Wuyts WA, et al. IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 2003; 24:20-28.
35. Kaneda H, Waddell TK, de Perrot M, et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006; 6:544-551.
36. De Perrot M, Sekine Y, Fischer S, et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002; 165:211-215.
37. Fisher AJ, Donnelly SC, Hirani N, et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001; 163:259-265.
38. Anraku M, Cameron MJ, Waddell TK, et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplant 2008; 8:2140-2148.
39. Kang CH, Anraku M, Cypel M, et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant 2011; 30:289-298.
40. Ray M, Dharmarajan S, Freudenberg J, et al. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7:2396-2405.
41. Das J, Kelley SO. Protein detection using arrayed microsensor chips: tuning sensor footprint to achieve ultrasensitive readout of CA-125 in serum and whole blood. Anal Chem 2011; 83:1167-1172.
42. Sage AT, Besant JD, Mahmoudian L, et al. Fractal circuit sensors enable rapid quantification of biomarkers for donor lung assessment for transplantation. Sci Adv 2015; 1:e1500417.
43. Frank JA, Briot R, Lee JW, et al. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007; 293:L52-L59.
44. Inci I, Ampollini L, Arni S, et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008; 27:1229-1236.
45. Karamanou DM, Perry J, Walden HR, et al. The effect of ex-vivo perfusion on the microbiological profile of the donor lung. J Heart Lung Transplant 2010; 29 (Suppl):S94.
46. Bonato R, Machuca TN, Cypel M, et al. Ex vivo treatment of infection in human donor lungs. J Heart Lung Transplant 2012; 31 (Suppl):S97-S98.
47. Nakajima D, Cypel M, Bonato R, et al. Ex vivo perfusion treatment of infection in human donor lungs. Am J Transplant 2016; 16:1229-1237.
48. Martens A, Montoli M, Faggi G, et al. Argon and xenon ventilation during prolonged ex vivo lung perfusion. J Surg Res 2016; 201:44-52.
49. Yeung JC, Wagnetz D, Cypel M, et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre-and post-lung transplantation in the pig. Mol Ther 2012; 20:1204-1211.
50. Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. Coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 2009; 106:16357-16362.
51. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010; 16:927-933.
52. Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science 2010; 329:538-541.